Table 2.
Response to treatment, disease progression, and survival
| W and W | CT | Ri-CT | RT-CT | RT | Ri | |
|---|---|---|---|---|---|---|
|
Responses |
|
|
|
|
|
|
|
CR |
|
69.2% |
75% |
94.7% |
80.9% |
57.1% |
|
PR |
|
19.2% |
16.7% |
5.3% |
9.5% |
42.9% |
|
SD |
|
0 |
2.8% |
0 |
0 |
0 |
|
PD |
|
11.6% |
5.5% |
0 |
9.5% |
0 |
|
Relapse rate |
- |
69.2% |
38.9% |
84.2% |
90.5% |
42.9% |
|
Median PFS 7,5 y |
26% |
23% |
60% |
26% |
19% |
- |
| Median OS 7.5y | 72% | 74% | 74% | 67% | 66% | 100% |
CR complete response, PR partial response, SD stable disease, PD progressive disease, OS overall survival, PFS progression free survival.